NO986088D0 - Polypeptider med evnen til Õ danne antigenbindende strukturer med spesifisi - Google Patents
Polypeptider med evnen til Õ danne antigenbindende strukturer med spesifisiInfo
- Publication number
- NO986088D0 NO986088D0 NO986088A NO986088A NO986088D0 NO 986088 D0 NO986088 D0 NO 986088D0 NO 986088 A NO986088 A NO 986088A NO 986088 A NO986088 A NO 986088A NO 986088 D0 NO986088 D0 NO 986088D0
- Authority
- NO
- Norway
- Prior art keywords
- polypeptides
- antigen binding
- specificity
- ability
- binding structures
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/80—Antibody or fragment thereof whose amino acid sequence is disclosed in whole or in part
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96810421 | 1996-06-24 | ||
PCT/EP1997/003253 WO1997049809A1 (en) | 1996-06-24 | 1997-06-20 | Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use |
Publications (3)
Publication Number | Publication Date |
---|---|
NO986088D0 true NO986088D0 (no) | 1998-12-23 |
NO986088L NO986088L (no) | 1999-02-24 |
NO327947B1 NO327947B1 (no) | 2009-10-26 |
Family
ID=8225636
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19986088A NO327947B1 (no) | 1996-06-24 | 1998-12-23 | Polypeptider som kan danne antigenbindende strukturer med spesifisitet for Rhesus D-antigener, DNA-sekvenser, fremgangsmater for seleksjon av rekombinante polypeptider som kan danne antigenbindende strukturer med spesifisitet for Rhesus D-antigener, anti-Rhesus D-antistoffer, framgangsmate for fremstilling av fullstendige anti-Rhesus D-antistoffer, farmasoytisk preparat samt diagnostisk preparat for Rhesus D-type bestemmelse |
Country Status (23)
Country | Link |
---|---|
US (3) | US7038020B1 (no) |
EP (1) | EP0920509B1 (no) |
JP (1) | JP3841360B2 (no) |
KR (1) | KR100361449B1 (no) |
AT (1) | ATE272116T1 (no) |
AU (1) | AU722127B2 (no) |
BG (1) | BG64534B1 (no) |
BR (1) | BR9709958A (no) |
CA (1) | CA2258494C (no) |
CZ (1) | CZ296807B6 (no) |
DE (1) | DE69730031T2 (no) |
DK (1) | DK0920509T3 (no) |
ES (1) | ES2224255T3 (no) |
HU (1) | HUP9902605A3 (no) |
IL (1) | IL127595A (no) |
IS (1) | IS2220B (no) |
NO (1) | NO327947B1 (no) |
NZ (1) | NZ333329A (no) |
PL (1) | PL186019B1 (no) |
RU (1) | RU2204602C2 (no) |
SK (1) | SK284879B6 (no) |
TR (1) | TR199802692T2 (no) |
WO (1) | WO1997049809A1 (no) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002530080A (ja) * | 1998-11-19 | 2002-09-17 | インサイト・ファーマスーティカルズ・インコーポレイテッド | 免疫グロブリン・スーパーファミリー・タンパク質 |
EP1106625A1 (en) * | 1999-11-17 | 2001-06-13 | ZLB Bioplasma AG | Rhesus D specific peptide sequences |
FR2807767B1 (fr) | 2000-04-12 | 2005-01-14 | Lab Francais Du Fractionnement | Anticorps monoclonaux anti-d |
DK1276855T3 (da) * | 2000-04-17 | 2012-11-26 | Dyax Corp | Fremgangsmåde til konstruktion af visningsbiblioteker over genetiske pakker for medlemmer af en diversificeret peptidfamilie |
US8288322B2 (en) | 2000-04-17 | 2012-10-16 | Dyax Corp. | Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries |
WO2002046435A2 (en) * | 2000-12-05 | 2002-06-13 | Alexion Pharmaceuticals, Inc. | Engineered plasmids and their use for in situ production of genes |
EP1360288B1 (en) | 2000-12-18 | 2011-02-16 | Dyax Corp. | Focused libraries of genetic packages |
AU2016225923B2 (en) * | 2001-04-17 | 2018-07-05 | Takeda Pharmaceutical Company Limited | Novel Methods of Constructing Libraries Comprising Displayed and/or Expressed Members of a Diverse Family of Peptides, Polypeptides or Proteins and the Novel Libraries |
US20040067532A1 (en) | 2002-08-12 | 2004-04-08 | Genetastix Corporation | High throughput generation and affinity maturation of humanized antibody |
ATE548657T1 (de) | 2004-07-20 | 2012-03-15 | Symphogen As | Prozedur zur strukturellen charakterisierung rekombinanter polyclonaler proteine oder einer polyclonalen zelllinie |
EP1771483A1 (en) | 2004-07-20 | 2007-04-11 | Symphogen A/S | Anti-rhesus d recombinant polyclonal antibody and methods of manufacture |
GB0706558D0 (en) * | 2007-04-03 | 2007-05-09 | Common Services Agency For The | Diagnostic assay |
CA2697193C (en) | 2007-09-14 | 2017-06-06 | Adimab, Inc. | Rationally designed, synthetic antibody libraries and uses therefor |
US8877688B2 (en) | 2007-09-14 | 2014-11-04 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
EP2045602A1 (en) | 2007-10-04 | 2009-04-08 | Symphogen A/S | Potency assay |
WO2009114815A1 (en) | 2008-03-13 | 2009-09-17 | Dyax Corp | Libraries of genetic packages comprising novel hc cdr3 designs |
EP2281078B1 (en) | 2008-04-24 | 2014-10-22 | Dyax Corporation | Libraries of genetic packages comprising novel hc cdr1, cdr2, and cdr3 and novel lc cdr1, cdr2, and cdr3 designs |
AU2011279073B2 (en) | 2010-07-16 | 2016-06-09 | Adimab, Llc | Antibody libraries |
MX2015005719A (es) * | 2012-11-06 | 2016-01-12 | Medimmune Llc | Terapias de combinacion que usan moleculas de union anti-psl y pcrv de pseudomonas. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2127434A (en) | 1982-09-17 | 1984-04-11 | Univ London | A human monoclonal antibody against Rhesus D antigen |
GB8925590D0 (en) * | 1989-11-13 | 1990-01-04 | Central Blood Lab Authority | Monoclonal antibodies |
-
1997
- 1997-06-20 KR KR10-1998-0710975A patent/KR100361449B1/ko not_active IP Right Cessation
- 1997-06-20 US US09/147,443 patent/US7038020B1/en not_active Expired - Fee Related
- 1997-06-20 HU HU9902605A patent/HUP9902605A3/hu unknown
- 1997-06-20 CZ CZ0395998A patent/CZ296807B6/cs not_active IP Right Cessation
- 1997-06-20 EP EP97929244A patent/EP0920509B1/en not_active Expired - Lifetime
- 1997-06-20 AT AT97929244T patent/ATE272116T1/de active
- 1997-06-20 JP JP50232398A patent/JP3841360B2/ja not_active Expired - Lifetime
- 1997-06-20 TR TR1998/02692T patent/TR199802692T2/xx unknown
- 1997-06-20 DK DK97929244T patent/DK0920509T3/da active
- 1997-06-20 AU AU33423/97A patent/AU722127B2/en not_active Expired
- 1997-06-20 IL IL12759597A patent/IL127595A/xx not_active IP Right Cessation
- 1997-06-20 SK SK1761-98A patent/SK284879B6/sk not_active IP Right Cessation
- 1997-06-20 PL PL97330794A patent/PL186019B1/pl not_active IP Right Cessation
- 1997-06-20 DE DE69730031T patent/DE69730031T2/de not_active Expired - Lifetime
- 1997-06-20 BR BR9709958A patent/BR9709958A/pt not_active Application Discontinuation
- 1997-06-20 CA CA002258494A patent/CA2258494C/en not_active Expired - Fee Related
- 1997-06-20 RU RU99101121/13A patent/RU2204602C2/ru not_active IP Right Cessation
- 1997-06-20 ES ES97929244T patent/ES2224255T3/es not_active Expired - Lifetime
- 1997-06-20 WO PCT/EP1997/003253 patent/WO1997049809A1/en active IP Right Grant
- 1997-06-20 NZ NZ333329A patent/NZ333329A/xx not_active IP Right Cessation
-
1998
- 1998-12-11 IS IS4922A patent/IS2220B/is unknown
- 1998-12-15 BG BG103016A patent/BG64534B1/bg unknown
- 1998-12-23 NO NO19986088A patent/NO327947B1/no not_active IP Right Cessation
-
2005
- 2005-06-20 US US11/155,775 patent/US7399471B2/en not_active Expired - Fee Related
-
2006
- 2006-01-18 US US11/333,197 patent/US7429647B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO986088D0 (no) | Polypeptider med evnen til Õ danne antigenbindende strukturer med spesifisi | |
TR199801722T2 (xx) | Peptit imm�nojenler. | |
WO2002072636A3 (en) | Crystals of whole antibodies and fragments thereof and methods for making and using them | |
ATE196314T1 (de) | Verfahren und zusammensetzungen zur verhinderung von entzündungen und angiogenese enthaltend säugetieren cd97 alpha untereinheit | |
WO2000037025A3 (en) | Antibodies to truncated vegf-d and uses thereof | |
WO2001093913A3 (en) | T cell receptor fusions and conjugates and methods of use thereof | |
EP0651818A4 (en) | IMMUNOGENIC PEPTIDES, ANTIBODIES AND USES THEREOF IN CONNECTION WITH THE BINDING OF THE CD4 MOLECULE RECEPTOR. | |
WO1998050547A3 (en) | Human toll-like receptor proteins, related reagents and methods | |
IL221708A0 (en) | Polyclonal goat anti-hla class ii antibody for treatment of disease involving proliferative immune response | |
DE68925226D1 (de) | Monoklonale Antikörper | |
BR9810907A (pt) | Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico | |
AU6832398A (en) | Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof | |
EP1433792A3 (en) | Human receptor proteins, related reagents and methods | |
WO1996021734A3 (en) | P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods | |
CA2068222A1 (en) | Monoclonal antibodies | |
DK0845998T3 (da) | Lægemidler til immunbehandling indeholdende antistoffer, der specifikt genkender MHCII-antigenet hos en patient, der skal behandles | |
BR9106159A (pt) | Polipeptideo sintetico,vacina,estojo para detectar hiv ou anticorpos contra hiv,molecula de dna,composicao farmaceutica,anticorpo ou fragmento de ligacao de antigeno do mesmo,processos de terapia ou profilaxia de infeccao hiv,de detectar hiv,de diagnosticar infeccao hiv e para a manufatura de um polipeptideo sintetico,de uma composicao farmaceutica e de um anticorpo ou fragmento de ligacao do mesmo | |
ATE360695T1 (de) | Cortistatin: neuropeptide, zusammensetzungen und methoden | |
WO1999046379A3 (en) | Human receptor proteins; related reagents and methods | |
WO2001057219A3 (en) | Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods | |
WO2002051237A3 (en) | Helicobacter proteins, nucleic acids and uses thereof | |
HK1048323A1 (en) | Production of mammary secretion antibodies in farmanimals | |
WO1999002564A3 (de) | Ancrod spezifische monoklonale antikörper, antikörperfragmente, deren mischungen oder derivate und deren verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |